Euan Walpole
Princess Alexandra Hospital, QLD, Australia
Euan Walpole has had an appointment as a specialist in medical oncology at Princess Alexandra Hospital since 1990. He has been active including as principal investigator in multiple clinical trial and has been Chairman of the Medical Oncology Group of Australia. He has been Medical Director of the Division of Cancer Services at PAH since 2005. He led the implementation of clinical information systems in cancer in Queensland with the radiation oncology information system and pharmacy oncology information system. He is also actively involved through Cancer Alliance Queensland, which is managed within the clinical division of PAH, to investigate and measure quality of cancer care in Queensland with reporting KPI’s.
Presentations this author is a contributor to:
SIRFLOX: Randomised phase III trial comparing first-line mFOLFOX6 ± bevacizumab (bev) versus mFOLFOX6 ± bev + selective internal radiation therapy (SIRT) in patients with metastatic colorectal cancer (mCRC) - analysis by presence or absence of extra-hepatic metastases, bev treatment and site of first progression (#20)
11:30 AM
Peter Gibbs
Best of the Best Orals - Clinical research
Lenalidomide use in relapsed or refractory multiple myeloma patients at five large Queensland public hospitals. (#228)
3:00 PM
Daniel McKavanagh
Posters1